Article
Small RNAs in plasma extracellular vesicles define biomarkers of premanifest changes in Huntington’s disease
2023-12-04
Abstract excerpt
Despite the advances in the understanding of Huntington’s disease (HD), there is the need for molecular biomarkers to categorize mutation-carriers during the preclinical stage of the disease preceding the functional decline. Small RNAs (sRNAs) are a promising source of biomarkers since their expression levels are highly sensitive to pathobiological processes. Here, using an optimized method for plasma extracellula...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 60cc9f69-2379-5548-99e0-bfb9e88ba3e7
- DOI
- 10.1101/2023.12.01.568823
